CFH and hemolytic-uremic syndrome: Recent insights into the disease reveal that almost 60% of atypical HUS patients exhibit gene mutations encoding complement-regulating proteins, leading to atypical HUS presentation in children without autoimmune anti-factor H antibodies [5].